Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on Psoriatic Arthritis : At a Glance
Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects both the skin and joints, typically developing in individuals with psoriasis. Characterized by joint pain, stiffness, and swelling, PsA can lead to significant disability if not properly managed. It presents in various forms, including symmetrical arthritis, asymmetrical oligoarthritis, and spondylitis, each with distinct clinical features. Early diagnosis is crucial to prevent joint damage and maintain quality of life, as PsA can be progressive and debilitating.
Management of Psoriatic Arthritis involves a combination of treatments aimed at controlling inflammation, reducing pain, and improving joint function. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used for mild cases, while disease-modifying antirheumatic drugs (DMARDs) and biologics, such as TNF inhibitors and IL-17 inhibitors, are crucial for more severe cases. Biologics have revolutionized PsA treatment by targeting specific immune pathways involved in the disease process, offering significant improvements in both skin and joint symptoms. Regular monitoring and a multidisciplinary approach are essential to address the diverse manifestations of PsA and to adjust treatment as needed for optimal patient outcomes.
See More Webinars @ Hidoc Webinars
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation